Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Genomics, Genpathway Partner to Provide ChIP-seq Service

Premium

Beckman Coulter Genomics and Genpathway are partnering to provide customers with whole-genome chromatin immunoprecipitation sequencing services, the companies said this week.

The new service, which is available worldwide, expands the DNA sequencing applications portfolio of Beckman Coulter Genomics, headquartered in Danvers, Mass.

Taking advantage of Genpathway's experience with ChIP, the service includes experimental design, antibody qualification, ChIP assays, next-generation sequencing, and data analysis.

Beckman Coulter Genomics, which provides genomic services as well as nucleic acid purification products, resulted from a merger of Beckman Coulter's Agencourt Biosciences with Cogenics last year.

Genpathway is an early-stage pharmacogenomics company providing drug and biomarker discovery and development services. The company uses a proprietary ChIP technology to understand gene regulation and genetic pathways.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.